Sponsor
NovImmune S.A.
Chemin Du Pre-Fleuri 15, 1228
About the sponsor
NovImmune S.A. focuses on solid malignancies with an emphasis on tumour-directed immune therapies for advanced, metastatic, and recurrent cancer.
- Advanced solid cancers
- Metastatic disease
- Recurrent malignancies
The clinical portfolio is centered on immune-based approaches in patients with limited treatment options across multiple tumour types.
Try clearing a filter, or search the whole catalogue.
Are you running a clinical trial?
Increase visibility for your trials and help patients find your site through our platform.